Vanderbilt Ingram Cancer Center

Cancer Center patients make their musical dreams come true

Rob Schieber and Jordan Lawhead each moved to Nashville to pursue a career in music. Songwriter and publisher Kris Bergsnes introduced them knowing they were both cancer survivors.

Endowed fellowships help create personal connections

When former Nashvillian Carol O’Hare speaks about a specific group of physicians at Vanderbilt-Ingram Cancer Center (VICC), her voice softens, and she refers to them affectionately as “my fellows.”

Cancer expert Thompson to deliver May 5 Flexner Discovery Lecture

Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, will deliver the next Flexner Discovery Lecture on May 5.

A smiling woman in her 50s in front of a rock wall.

Study explores how some breast cancers resist treatment

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

VICC’s Annual Scientific Retreat set for May 6

Scientists, physicians, staff members and patients interested in the latest in cancer research are invited to attend the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat to be held Friday, May 6, 8 a.m. – 3 p.m., at the Vanderbilt University Student Life Center.

Pietenpol named Executive Vice President for Research

Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1.

1 32 33 34 35 36 52